(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KIOMED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KIOMED

ST13

US500000079203384

Class

1, 5, 10, 42, 44

Filing

79203384

Registration

5420385

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

10/25/2025

Trademark type

Combined

Nice classes

1, 5, 10, 42, 44

Filing date

09/29/2016

Registration date

03/13/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/27/2024

Last transaction

10/25/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

BE

Examiner

MIDDLETON,BERNICE L

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

KiOmed Pharma, Société Anonyme

Representatives

Dmitriy O. Makarov IpHorgan Ltd.

Technical classification

Nice Classes

Class 1Class 5Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalschitosanchitinchitosan derivatives; chemicalschitin derivatives; chemical products for use in industry or science; chemical additives for manufacture of pharmaceutical productsvaccines and cosmetics; active chemical ingredients used in the manufacture of pharmaceutical products for treating musculo-sketletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally

Class 5

Pharmaceutical preparations for the treatment and prevention of musculo-sketletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; veterinary preparations for the treatment and prevention of musculo-sketletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally in farm animals and domestic pets; sanitary products for medical purposes; dietetic food and substanceswheat-free and gluten-free pastacrakersbread to accommodate special medical and health conditionsdietetic sugar and infusion adapted for medical or veterinary use; materials for medical dressings; material for dental fillings and dental impressions; disinfectants for hygienic purposesdisinfectants for sanitary purposesdisinfectants for medical instruments; bath preparations for medical use; chemical preparations for medical or pharmaceutical use for the treatment and prevention of musculoskeletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; pharmaceutical products based on materials of plant origin for the treatment and prevention of musculoskeletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; pharmaceutical products based on chitosanchitinchitosan derivatives of vegetable originchitin derivatives for the treatment and prevention of musculoskeletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; vaccines; preparations for vaccines

Class 10

Surgicalmedicaldental and veterinary apparatus and instrumentsvertebral osteosynthesis staple-shaped apparatus and instrumentsdevices used in orthopedic surgery to position surgical instrumentsimplants and/or patients' limbsorthopedic fixation device used in orthopedic transplant and/or implant surgerysurgical and medical apparatus and instruments for use in spinalgeneralorthopedic surgery; artificial limbseyes and teeth; orthopedic articlesnamely orthopedic cushions and bracessuture material; bonejointhip and breast prosthesesstaple-shaped prostheses for the spinal columnstaple-shaped prostheses of vertebral discs; artificial implantsnamely to fill joints and bonesto fill the dermis and other conjunctival tissuesartificial implants to be used as surgical aids

Class 42

Scientific servicesnamely researchtestinganalysis and development services in the fields of medicinepharmaceutical productschemistrybiochemistrybiologybiotechnology or bacteriology; design and development of medical technologies; conducting clinical trials and preliminary evaluations for othersparticularly for pharmaceutical products; evaluation of pharmaceutical products; scientific research and development services relating to vaccines and medicines; scientific researchanalysis and development services in chemistrybiochemistrybiologybiotechnology or bacteriology; scientific researchanalysis and development services in cosmetology; basic scientific research and clinical research in the fields of sciencenamely clinical trials and medicine; scientific researchtesting and development of products developed using materials of vegetable origin; scientific researchtesting and development of products developed using chitosanchitinchitosan derivatives of vegetable originchitin derivatives; carrying out technical or scientific studies in the fields of medicinepharmaceutical productschemistrybiochemistrybiologybiotechnology or bacteriology; provision of information and a database relating to scientific and medical research and development in the field of pharmaceutical productschemistrybiochemistrybiologybiotechnology or bacteriology

Class 44

Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical assistance; cosmetic surgery; hospital services; nursing homes; convalescence or rest homes; opticians' services; alternative medicine services; health counseling services; medical equipment rental; telemedicine services; therapeutic servicesnamely therapeutic radiological services

Publications

History of USPTO decisions and trademark events.

31 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

10/24/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

10/02/2025

INPC

INVALIDATION PROCESSED

10/02/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

05/27/2025

C71T

CANCELLED SECTION 71

09/27/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/13/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/07/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/13/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/19/2018

FIMP

FINAL DISPOSITION PROCESSED

06/19/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/13/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

03/13/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/26/2017

PUBO

PUBLISHED FOR OPPOSITION

12/26/2017

GPNX

NOTIFICATION PROCESSED BY IB

12/22/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/06/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/06/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/06/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/22/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/21/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/21/2017

RFNT

REFUSAL PROCESSED BY IB

04/09/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/23/2017

RFRR

REFUSAL PROCESSED BY MPU

03/23/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/22/2017

CNRT

NON-FINAL ACTION WRITTEN

03/21/2017

MAFR

APPLICATION FILING RECEIPT MAILED

03/21/2017

DOCK

ASSIGNED TO EXAMINER

03/17/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/17/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/16/2017

Continuous trademark protection

Get notified about every new filing that threatens KIOMED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.